Vol. 4 No. 1 (2023)

View Vol. 4 No. 1 (2023)

DOI: https://doi.org/10.17161/rrnmf.v4i1

Published: 2023-02-07

Full Issue

PDF

Letter from the Founding Facilitator

Letter from the Founding Facilitator for Volume 4, Issue 1

Richard J. Barohn, MD

1
- PDF

What’s on your Mind: Commentaries (Letters to the Facilitators)

FDA should protect the American people, and Pharma should pay!

Joshua Freeman, MD

2-3
- PDF
Medicare Advantage - Whose Advantage Is It?

Donald Frey, MD

4-5
- PDF

New Discoveries and Original Research

Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravis: follow up survey

Yingkai Li, Ph.D., Yohei Harada M.D., Marjan Cobbaert, M.P.H., Vern C. Juel, M.D., Lisa D. Hobson-Webb, M.D., Shruti M. Raja, M.D., Natalia L. Gonzalez, M.D., Jeffrey T. Guptill, M.D.

6-13
- PDF
Emergent Comorbid Events in First Year of Immunomodulatory Treatment in Adults With Generalized Myasthenia Gravis treated in a Neurology Clinic: A Retrospective Review

Nakul Katyal, MD, Brian Blankenship, MD, Naureen Narula, MD, Eric Grisham, BAS, Raghav Govindarajan, MD

14-19
- PDF
The Effects of Testosterone and Transcutaneous Muscle Stimulation on Strength and Muscle Mass in Myotonic Dystrophy

Salman Bhai, MD, Alexis Lizarraga, MD, Morgan McCreary, PhD, Seth Kolkin, MD, John Kissel, MD, Richard J. Barohn, MD

20-26
- PDF

Clinic and Case Reports

A novel DOK7 mutation causing limb-girdle congenital myasthenic syndrome

Adam S. Reynolds, MD, Ava Y. Lin, MD, PhD, Leo H. Wang, MD, PhD

27-31
- PDF
Steroid Responsive Acute Inflammatory Demyelinating Polyneuropathy Induced by an Immune Check Point Inhibitor

Najwa Al-Bustani, MD, Zulfiqar Hussain, MD

32-33
- PDF
Non-5q Spinal Muscular Atrophy in a Patient With a Novel BICD2 Missense Variant

Nahee Park, BS, Michael M. Muriello, MD, Donald Basel, MD, Caroline A. Kielczewski, MS, Matthew Harmelink, MD

34-41
- PDF

Meetings (Abstracts, Summaries, Photographs from meetings, & Posters)

2022 KCMD Symposium Abstracts

Various Authors

42-73
- PDF